History can be a fickle guide to short-term events, and the course of technological or societal change is rarely smooth. However, over longer periods, it’s my view that threats to human progress are generally addressed: individuals and businesses innovate, economies grow, and living standards rise.
Humans navigate their way through crises in ways that often create entirely new sources of economic and market value. Importantly, the driving force behind that progress is not luck: it’s the story of human ingenuity.
As I write, it’s hard for me to overlook the history around me among the archives of Coutts clients. From the most famous biologist of all time, Charles Darwin, and the ‘father of modern surgery’, Lord Joseph Lister, to a musician who fundamentally transformed his field, Frederic Chopin, and our own pioneering Victorian philanthropist, Angela Burdett-Coutts… I am surrounded by the stories of innovators and adventurers who utterly transformed the boundaries of what was once thought possible.
But I’m also immediately thinking of a chapter of more recent history which we all remember acutely: a global health, social and economic crisis in the form of the covid-19 pandemic.
Lest anyone forget, in early 2020, global leaders grappled with an unprecedented crisis, with many lives lost and changed. In the background, the world economy also shut down, and equity markets fell.
Faced with a seemingly impassable road ahead, humanity compressed years of scientific progress into mere months. Cross-border and cross-sector (public and private) scientific collaboration and funding accelerated, and multiple vaccines were developed to save human lives. Before the covid-19 pandemic, traditional vaccine development took an average of 10-15 years, and the most quickly developed vaccine in history (for mumps) was four years in the making. The first covid-19 vaccine was ready in less than a year.
Innovation quite literally reopened the world and saved countless lives. Along the way, from an economic perspective, it also reignited growth, consumer demand and investor risk appetite.